Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
9 Months Ended
Dec. 31, 2018
Feb. 14, 2019
Document And Entity Information    
Entity Registrant Name AIT Therapeutics, Inc.  
Entity Central Index Key 0001641631  
Document Type 10-Q  
Document Period End Date Dec. 31, 2018  
Amendment Flag false  
Current Fiscal Year End Date --03-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   8,598,657
Trading Symbol AITB  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019